selpercatinibcabozantinibvandetanibGFRA4New England Journal of MedicineClinical Cancer ResearchMedullary thyroid cancer (MTC)EACRIUC-DenverTKIs+1 more
…static MTC. In the setting of progressive metastatic MTC, TKIs (selpercatinib, cabozantinib and vandetanib) can prolong survival for some pat…